Style | Citing Format |
---|---|
MLA | Suwan Y, et al.. "Peripapillary Perfused Capillary Density in Exfoliation Syndrome and Exfoliation Glaucoma Versus Poag and Healthy Controls: An Octa Study." Asia-Pacific Journal of Ophthalmology, vol. 7, no. 2, 2018, pp. 84-89. |
APA | Suwan Y, Geyman LS, Fard MA, Tantraworasin A, Chui TY, Rosen RB, Ritch R (2018). Peripapillary Perfused Capillary Density in Exfoliation Syndrome and Exfoliation Glaucoma Versus Poag and Healthy Controls: An Octa Study. Asia-Pacific Journal of Ophthalmology, 7(2), 84-89. |
Chicago | Suwan Y, Geyman LS, Fard MA, Tantraworasin A, Chui TY, Rosen RB, Ritch R. "Peripapillary Perfused Capillary Density in Exfoliation Syndrome and Exfoliation Glaucoma Versus Poag and Healthy Controls: An Octa Study." Asia-Pacific Journal of Ophthalmology 7, no. 2 (2018): 84-89. |
Harvard | Suwan Y et al. (2018) 'Peripapillary Perfused Capillary Density in Exfoliation Syndrome and Exfoliation Glaucoma Versus Poag and Healthy Controls: An Octa Study', Asia-Pacific Journal of Ophthalmology, 7(2), pp. 84-89. |
Vancouver | Suwan Y, Geyman LS, Fard MA, Tantraworasin A, Chui TY, Rosen RB, et al.. Peripapillary Perfused Capillary Density in Exfoliation Syndrome and Exfoliation Glaucoma Versus Poag and Healthy Controls: An Octa Study. Asia-Pacific Journal of Ophthalmology. 2018;7(2):84-89. |
BibTex | @article{ author = {Suwan Y and Geyman LS and Fard MA and Tantraworasin A and Chui TY and Rosen RB and Ritch R}, title = {Peripapillary Perfused Capillary Density in Exfoliation Syndrome and Exfoliation Glaucoma Versus Poag and Healthy Controls: An Octa Study}, journal = {Asia-Pacific Journal of Ophthalmology}, volume = {7}, number = {2}, pages = {84-89}, year = {2018} } |
RIS | TY - JOUR AU - Suwan Y AU - Geyman LS AU - Fard MA AU - Tantraworasin A AU - Chui TY AU - Rosen RB AU - Ritch R TI - Peripapillary Perfused Capillary Density in Exfoliation Syndrome and Exfoliation Glaucoma Versus Poag and Healthy Controls: An Octa Study JO - Asia-Pacific Journal of Ophthalmology VL - 7 IS - 2 SP - 84 EP - 89 PY - 2018 ER - |